These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23671649)

  • 1. Interaction between obesity and the NFKB1 - 94ins/delATTG promoter polymorphism in relation to incident acute coronary syndrome: a follow up study in three independent cohorts.
    Stegger JG; Schmidt EB; Berentzen TL; Tjønneland A; Vogel U; Rimm E; Sørensen TI; Overvad K; Jensen MK
    PLoS One; 2013; 8(5):e63004. PubMed ID: 23671649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
    Zou YF; Wang F; Feng XL; Tao JH; Zhu JM; Pan FM; Su H
    Tissue Antigens; 2011 Jan; 77(1):9-17. PubMed ID: 21155719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
    Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
    Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease.
    Rueda B; Núñez C; López-Nevot MA; Paz Ruiz M; Urcelay E; De la Concha EG; Martín J
    Scand J Gastroenterol; 2006 Apr; 41(4):420-3. PubMed ID: 16635909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
    J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.
    Zou YF; Yuan FL; Feng XL; Tao JH; Ding N; Pan FM; Wang F
    Cancer Invest; 2011 Jan; 29(1):78-85. PubMed ID: 21166501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes.
    Glas J; Török HP; Tonenchi L; Müller-Myhsok B; Mussack T; Wetzke M; Klein W; Epplen JT; Griga T; Schiemann U; Lohse P; Seiderer J; Schnitzler F; Brand S; Ochsenkühn T; Folwaczny M; Folwaczny C
    Inflamm Bowel Dis; 2006 Jul; 12(7):606-11. PubMed ID: 16804398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
    Riemann K; Becker L; Struwe H; Nückel H; Dührsen U; Alakus H; Winde G; Neuhäuser M; Rübben H; Schmitz KJ; Wohlschlaeger J; Schmid KW; Siffert W
    Pharmacogenet Genomics; 2006 Nov; 16(11):783-8. PubMed ID: 17047486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The
    Nowak H; Vornweg S; Rump K; Rahmel T; Unterberg M; Koos B; Schenker P; Viebahn R; Adamzik M; Bergmann L
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations.
    Vogel U; Jensen MK; Due KM; Rimm EB; Wallin H; Nielsen MR; Pedersen AP; Tjønneland A; Overvad K
    Atherosclerosis; 2011 Nov; 219(1):200-4. PubMed ID: 21726863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocortisone fails to abolish NF-κB1 protein nuclear translocation in deletion allele carriers of the NFKB1 promoter polymorphism (-94ins/delATTG) and is associated with increased 30-day mortality in septic shock.
    Schäfer ST; Gessner S; Scherag A; Rump K; Frey UH; Siffert W; Westendorf AM; Steinmann J; Peters J; Adamzik M
    PLoS One; 2014; 9(8):e104953. PubMed ID: 25133403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFKB1 promoter polymorphism: A new predictive marker of cytomegalovirus infection after kidney transplantation.
    Leone F; Gigliotti P; La Russa A; Lofaro D; Perri A; Vizza D; Lupinacci S; Toteda G; Bonofiglio M; Presta P; Talarico R; Aquino B; Bonofiglio R
    Transpl Infect Dis; 2019 Feb; 21(1):e13027. PubMed ID: 30431214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of NFKB1 -94insertion/deletion ATTG polymorphism to the susceptibility of gastrointestinal cancers: A meta-analysis.
    Wu H; Liang J
    J Cell Mol Med; 2021 Nov; 25(22):10674-10683. PubMed ID: 34672421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers.
    Lin SC; Liu CJ; Yeh WI; Lui MT; Chang KW; Chang CS
    Cancer Lett; 2006 Nov; 243(1):47-54. PubMed ID: 16387424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus.
    Orozco G; Sánchez E; Collado MD; López-Nevot MA; Paco L; García A; Jiménez-Alonso J; Martín J
    Tissue Antigens; 2005 Feb; 65(2):183-6. PubMed ID: 15713218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis.
    Liang M; Xu X; Gong Y; Tang Y; Lin L
    Dig Dis Sci; 2012 Sep; 57(9):2304-9. PubMed ID: 22828805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in Toll-like receptor and nuclear factor-kappa B genes and the risk of glioma.
    Kına I; Sultuybek GK; Soydas T; Yenmis G; Biceroglu H; Dirican A; Uzan M; Ulutin T
    Br J Neurosurg; 2019 Apr; 33(2):165-170. PubMed ID: 30450997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NFKB1 promoter polymorphism (-94ins/delATTG) alters nuclear translocation of NF-κB1 in monocytes after lipopolysaccharide stimulation and is associated with increased mortality in sepsis.
    Adamzik M; Schäfer S; Frey UH; Becker A; Kreuzer M; Winning S; Frede S; Steinmann J; Fandrey J; Zacharowski K; Siffert W; Peters J; Hartmann M
    Anesthesiology; 2013 Jan; 118(1):123-33. PubMed ID: 23249930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma.
    Varga G; Mikala G; Andrikovics H; Koszarska M; Balassa K; Ádám E; Kozma A; Tordai A; Masszi T
    Br J Haematol; 2015 Mar; 168(5):679-88. PubMed ID: 25363231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies.
    Fu W; Zhuo ZJ; Chen YC; Zhu J; Zhao Z; Jia W; Hu JH; Fu K; Zhu SB; He J; Liu GC
    Oncotarget; 2017 Feb; 8(6):9806-9822. PubMed ID: 28039461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.